Joseph Donia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Joseph Donia has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Luca Marelli
Department of Medical Biotechnology & Translational Medicine University of Milan Milan Italy
3 shared publications - James Shaw
University of Toronto
2 shared publications Luca Marelli
Department of Medical Biotechnology & Translational Medicine, University of Milan, Milan, Italy
2 shared publications- Philip Boyer
INOVAIT, Sunnybrook Research Institute
2 shared publications - Andrea Martani
University of Basel
1 shared publication - Benedetta Muda1 shared publication
Latest Publications
- Open Access
- 29 September 2026
- Published by Wiley in Sociology of Health & Illness
- Vol. 48 (8) , e70270
Secondary Use of Health Data in Canada and the European Union: Expectations, Frictions and the Politics of Scale
In this article, we trace expectations associated with efforts to promote secondary use of health data in Canada and the European Union. In Canada, we focus on initiatives enabling cross‐jurisdictional data access in a highly devolved federal system with parallel commitments to Indigenous data sovereignty. In the EU, we focus on the European Health Data Space, a new regulatory regime intended to facilitate access to health data for clinical care, research, policymaking and innovation across 27 member states. Drawing on a comparative analysis of policy documents and semi‐structured interviews across nine EU member states and four Canadian provinces and one territory, we find that despite institutional differences, secondary use in both jurisdictions is characterised by strikingly similar promissory vocabularies. We argue that these expectations are fundamentally ones of scale: They seek to render health data interoperable, comparable and usable to different ends. At the same time, we document shared frictions: between sovereignty and integration; between access and control; and between private assets and public goods. We understand these as spaces where competing valuations of health data are negotiated. We suggest that secondary use logics are progressively reorienting health systems, with implications for public value, equity and political collectives.
- 29 September 2026
- Published by Wiley in Sociology of Health & Illness
- Vol. 48 (8) , e70270
Open AccessSecondary Use of Health Data in Canada and the European Union: Expectations, Frictions and the Politics of Scale
In this article, we trace expectations associated with efforts to promote secondary use of health data in Canada and the European Union. In Canada, we focus on initiatives enabling cross‐jurisdictional data access in a highly devolved federal system with parallel commitments to Indigenous data sovereignty. In the EU, we focus on the European Health Data Space, a new regulatory regime intended to facilitate access to health data for clinical care, research, policymaking and innovation across 27 member states. Drawing on a comparative analysis of policy documents and semi‐structured interviews across nine EU member states and four Canadian provinces and one territory, we find that despite institutional differences, secondary use in both jurisdictions is characterised by strikingly similar promissory vocabularies. We argue that these expectations are fundamentally ones of scale: They seek to render health data interoperable, comparable and usable to different ends. At the same time, we document shared frictions: between sovereignty and integration; between access and control; and between private assets and public goods. We understand these as spaces where competing valuations of health data are negotiated. We suggest that secondary use logics are progressively reorienting health systems, with implications for public value, equity and political collectives.
- Open Access
- 31 August 2026
- Published by Elsevier in Social Science & Medicine
- Vol. 407
Selective visibility in datafied states: Examining the absence and presence of the European Health Data Space
- 31 August 2026
- Published by Elsevier in Social Science & Medicine
- Vol. 407
Open AccessSelective visibility in datafied states: Examining the absence and presence of the European Health Data Space
- Open Access
- 26 August 2026
- Published by Springer Nature in Canadian Journal of Public Health
- p. 1-5
Can Canada learn from the European Health Data Space?
Federal, provincial, and territorial governments in Canada are increasingly committed to promoting health data access and use. The European Union has advanced a bold vision for health data integration with the European Health Data Space (EHDS) Regulation, which entered into force in March 2025. As the first data space to take shape as part of the broader European Strategy for Data, the EHDS establishes a robust regulatory regime for both primary use (clinical care, including electronic health record certification) and secondary use (research, policymaking, and innovation). In this commentary, we outline what Canada can learn from the EHDS policy experience to ensure that debates about health data access and use in Canada remain connected to broader discussions about community rights, accountability, public value, and the practical challenges of integrating data across jurisdictions. In particular, we suggest a more explicit focus on the politics of health data access and use; a value-oriented approach; and situating individual rights in relation to community-oriented governance.
- 26 August 2026
- Published by Springer Nature in Canadian Journal of Public Health
- p. 1-5
Open AccessCan Canada learn from the European Health Data Space?
Federal, provincial, and territorial governments in Canada are increasingly committed to promoting health data access and use. The European Union has advanced a bold vision for health data integration with the European Health Data Space (EHDS) Regulation, which entered into force in March 2025. As the first data space to take shape as part of the broader European Strategy for Data, the EHDS establishes a robust regulatory regime for both primary use (clinical care, including electronic health record certification) and secondary use (research, policymaking, and innovation). In this commentary, we outline what Canada can learn from the EHDS policy experience to ensure that debates about health data access and use in Canada remain connected to broader discussions about community rights, accountability, public value, and the practical challenges of integrating data across jurisdictions. In particular, we suggest a more explicit focus on the politics of health data access and use; a value-oriented approach; and situating individual rights in relation to community-oriented governance.
- Open Access
- 1 January 2026
- Published by Elsevier in SSRN Electronic Journal
Governing the European Health Data Space (EHDS): Ethical and Political Perspectives on the TEHDAS2 Second Public Consultation
This white paper consolidates comments submitted to the TEHDAS2 second public consultation on the TEHDAS2 guidelines (September 2025). TEHDAS2 guidelines provide practical guidance and operational interpretation of key provisions of the European Health Data Space (EHDS) Regulation, aimed at supporting consistent implementation across Member States while allowing for national flexibility. TEHDAS2 guidance addresses core aspects of the secondary use framework of the EHDS, including fee structures, permitted and prohibited uses of health data, metadata cataloguing, data access application and request procedures, enforcement and sanctions, and individual opt-out mechanisms. Across the guidelines, foundational principles such as transparency, proportionality, non-discrimination, due process, competition neutrality, data minimization, and alignment with FAIR principles are emphasized. The guidelines also clarify procedural requirements, including compliance monitoring, verification and assessment workflows, coordination mechanisms, and transparency obligations at both national and EU levels. While the TEHDAS2 guidelines offer valuable operational clarity, our analysis identifies several areas where further specification, harmonization, or clarification would strengthen implementation. These include, among others: the rationale and consistency of fee models and accounting standards; cross-border coordination and enforcement; alignment with GDPR requirements and AI governance; interpretation of allowed purposes and public interest; handling of intellectual property and trade secrets; metadata scalability and resource constraints; differentiation between data and dataset quality; and the practical implementation of opt-out mechanisms, particularly in relation to genetic data, vulnerable populations, and communication strategies.
- 1 January 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessGoverning the European Health Data Space (EHDS): Ethical and Political Perspectives on the TEHDAS2 Second Public Consultation
This white paper consolidates comments submitted to the TEHDAS2 second public consultation on the TEHDAS2 guidelines (September 2025). TEHDAS2 guidelines provide practical guidance and operational interpretation of key provisions of the European Health Data Space (EHDS) Regulation, aimed at supporting consistent implementation across Member States while allowing for national flexibility. TEHDAS2 guidance addresses core aspects of the secondary use framework of the EHDS, including fee structures, permitted and prohibited uses of health data, metadata cataloguing, data access application and request procedures, enforcement and sanctions, and individual opt-out mechanisms. Across the guidelines, foundational principles such as transparency, proportionality, non-discrimination, due process, competition neutrality, data minimization, and alignment with FAIR principles are emphasized. The guidelines also clarify procedural requirements, including compliance monitoring, verification and assessment workflows, coordination mechanisms, and transparency obligations at both national and EU levels. While the TEHDAS2 guidelines offer valuable operational clarity, our analysis identifies several areas where further specification, harmonization, or clarification would strengthen implementation. These include, among others: the rationale and consistency of fee models and accounting standards; cross-border coordination and enforcement; alignment with GDPR requirements and AI governance; interpretation of allowed purposes and public interest; handling of intellectual property and trade secrets; metadata scalability and resource constraints; differentiation between data and dataset quality; and the practical implementation of opt-out mechanisms, particularly in relation to genetic data, vulnerable populations, and communication strategies.
- Open Access
- 17 September 2025
- Published by Elsevier in Health Policy
- Vol. 162, 105443
Anticipating ethical and social dimensions of the European Health Data Space: A rapid systematic review
- 17 September 2025
- Published by Elsevier in Health Policy
- Vol. 162, 105443
Open AccessAnticipating ethical and social dimensions of the European Health Data Space: A rapid systematic review
- Open Access
- 9 July 2025
- Published by SAGE Publications in Social Studies of Science
- Vol. 56 (1) , 75-95
Making data markets: Assetization, valuation, and proxy work in a digital health start-up
Digital data are increasingly framed as essential resources in health and medicine, implicating diverse actors who work to transform them into different forms of value. In this article we focus on the diverse and contingent valuation practices that shaped an artificial intelligence-enabled ‘smart’ health technology and the data it generated at different moments in time, and the corresponding asset forms that were envisioned, developed, tested, and marketed. We also outline the role of assetization as a contested but essential design and marketing activity, and introduce the notion of proxy work as an intermediary between data generation and assetization, where people, infrastructures, and other material devices are arranged in such a way that data become capable of ‘standing in’ for something else, allowing accountable forms of value to be realized across multiple sites. We conclude with a discussion of the consequences of assetization as a dominant lens through which governments, firms, and other actors increasingly understand the value of digital health data, and the different health-related futures those practices make possible.
- 9 July 2025
- Published by SAGE Publications in Social Studies of Science
- Vol. 56 (1) , 75-95
Open AccessMaking data markets: Assetization, valuation, and proxy work in a digital health start-up
Digital data are increasingly framed as essential resources in health and medicine, implicating diverse actors who work to transform them into different forms of value. In this article we focus on the diverse and contingent valuation practices that shaped an artificial intelligence-enabled ‘smart’ health technology and the data it generated at different moments in time, and the corresponding asset forms that were envisioned, developed, tested, and marketed. We also outline the role of assetization as a contested but essential design and marketing activity, and introduce the notion of proxy work as an intermediary between data generation and assetization, where people, infrastructures, and other material devices are arranged in such a way that data become capable of ‘standing in’ for something else, allowing accountable forms of value to be realized across multiple sites. We conclude with a discussion of the consequences of assetization as a dominant lens through which governments, firms, and other actors increasingly understand the value of digital health data, and the different health-related futures those practices make possible.
- Open Access
- 23 April 2025
- Published by SAGE Publications in Big Data & Society
- Vol. 12 (2)
Algorithmic accountabilities and health systems: A review and sociomaterial approach
The perceived importance and difficulty of accounting for algorithms in health systems continues to inform scholarship and practice across diverse fields. While accountability is often framed as a normative good, less clear is exactly what kind of normative work accountability is expected to do, and how it is expected to do it. Drawing on contributions from science and technology studies, and especially sociomaterial perspectives on governance, in this article I review how algorithmic accountability has been conceptualized in the academic and grey literature. I introduce five normative logics characterizing discussions of algorithmic accountability: (1) accountability as verification, (2) accountability as participation, (3) accountability as social licence, (4) accountability as fiduciary duty, and (5) accountability as compliance. I critically engage with the styles of valuation these are predicated upon, including how each configures the algorithm as an object of reference, and discuss the implications of this approach for understanding how health-related worlds are created and sustained, and how they might be otherwise.
- 23 April 2025
- Published by SAGE Publications in Big Data & Society
- Vol. 12 (2)
Open AccessAlgorithmic accountabilities and health systems: A review and sociomaterial approach
The perceived importance and difficulty of accounting for algorithms in health systems continues to inform scholarship and practice across diverse fields. While accountability is often framed as a normative good, less clear is exactly what kind of normative work accountability is expected to do, and how it is expected to do it. Drawing on contributions from science and technology studies, and especially sociomaterial perspectives on governance, in this article I review how algorithmic accountability has been conceptualized in the academic and grey literature. I introduce five normative logics characterizing discussions of algorithmic accountability: (1) accountability as verification, (2) accountability as participation, (3) accountability as social licence, (4) accountability as fiduciary duty, and (5) accountability as compliance. I critically engage with the styles of valuation these are predicated upon, including how each configures the algorithm as an object of reference, and discuss the implications of this approach for understanding how health-related worlds are created and sustained, and how they might be otherwise.
- 22 October 2024
- Published by Springer Nature in AI and Ethics
- Vol. 5 (3) , 2815-2828
Lifecycles, pipelines, and value chains: toward a focus on events in responsible artificial intelligence for health
- 22 October 2024
- Published by Springer Nature in AI and Ethics
- Vol. 5 (3) , 2815-2828
Lifecycles, pipelines, and value chains: toward a focus on events in responsible artificial intelligence for health
- 28 June 2022
- Published by Elsevier in Health Policy and Technology
- Vol. 11 (3)
Regulatory regimes and procedural values for health-related motion data in the United States and Canada
- 28 June 2022
- Published by Elsevier in Health Policy and Technology
- Vol. 11 (3)
Regulatory regimes and procedural values for health-related motion data in the United States and Canada
- Open Access
- 19 August 2021
- Published by Springer Nature in Science and Engineering Ethics
- Vol. 27 (5) , 1-32
Ethics and Values in Design: A Structured Review and Theoretical Critique
A variety of approaches have appeared in academic literature and in design practice representing “ethics-first” methods. These approaches typically focus on clarifying the normative dimensions of design, or outlining strategies for explicitly incorporating values into design. While this body of literature has developed considerably over the last 20 years, two themes central to the endeavour of ethics and values in design (E + VID) have yet to be systematically discussed in relation to each other: (a) designer agency, and (b) the strength of normative claims informing the design process. To address this gap, we undertook a structured review of leading E + VID approaches and critiques, and classified them according to their positions on normative strength, and views regarding designer agency. We identified 18 distinct approaches and 13 critiques that met the inclusion criteria for our review. Included papers were distributed across the spectrum of views regarding normative strength, and we found that no approaches and only one critique represented a view characteristic of “low” designer agency. We suggest that the absence of “low” designer agency approaches results in the neglect of crucial influences on design as targets of intervention by designers. We conclude with suggestions for future research that might illuminate strategies to achieve ethical design in information mature societies, and argue that without attending to the tensions raised by balancing normatively “strong” visions of the future with limitations imposed on designer agency in corporate-driven design settings, “meaningful” ethical design will continue to encounter challenges in practice.
- 19 August 2021
- Published by Springer Nature in Science and Engineering Ethics
- Vol. 27 (5) , 1-32
Open AccessEthics and Values in Design: A Structured Review and Theoretical Critique
A variety of approaches have appeared in academic literature and in design practice representing “ethics-first” methods. These approaches typically focus on clarifying the normative dimensions of design, or outlining strategies for explicitly incorporating values into design. While this body of literature has developed considerably over the last 20 years, two themes central to the endeavour of ethics and values in design (E + VID) have yet to be systematically discussed in relation to each other: (a) designer agency, and (b) the strength of normative claims informing the design process. To address this gap, we undertook a structured review of leading E + VID approaches and critiques, and classified them according to their positions on normative strength, and views regarding designer agency. We identified 18 distinct approaches and 13 critiques that met the inclusion criteria for our review. Included papers were distributed across the spectrum of views regarding normative strength, and we found that no approaches and only one critique represented a view characteristic of “low” designer agency. We suggest that the absence of “low” designer agency approaches results in the neglect of crucial influences on design as targets of intervention by designers. We conclude with suggestions for future research that might illuminate strategies to achieve ethical design in information mature societies, and argue that without attending to the tensions raised by balancing normatively “strong” visions of the future with limitations imposed on designer agency in corporate-driven design settings, “meaningful” ethical design will continue to encounter challenges in practice.